Quadruple therapy w/ #ARNI , BB, MRA, #SGLT2i led to decreased risk of CV death & HHF in pts w/ #HFmrEF & #HFpEF . This benefit is largely driven by ARNI, MRA, SGLT2i, which was more pronounced in HFmrEF. bit.ly/3UtIEOD

#JACCHF #GDMT #CHF Stefanos Zafeiropoulos, MD, MS, PhD George Giannakoulas

#BetaBlocker use in #HFpEF and #HFmrEF ❓

In this month’s issue of #JACCHF , analysis of #DELIVER trial shows:

♥️ 4 out of 5 px were treated with #BB
♥️ #BB use wasn't linked to #worseningHF or #CVdeath
♥️Benefits of #Dapagliflozin remained consistent regardless of #BB
➡️➡️

2.  All tiers except adult rating for FT had poor agreement/consistency across the study period. In addition, the ratings had poor reliability.

Transplant Center performance is reported in public domain in United States? We reviewed their stability, volatility and reliability for pediatric and adult heart transplant centers.

JACC Journals : jacc.org/doi/10.1016/j.…

Cleveland Clinic Heart, Vascular & Thoracic BiykemBozkurt

A 🧵:

#whycmr #blackmeninmedicine #cardioonc

📣📣Introducing 'Au Contraire' section of JACC Journals #JACCHF
Share unconventional ideas, challenge accepted wisdom, & present alternative perspectives in #HF

BiykemBozkurt Eiran Gorodeski, MD, MPH Novi Tham Nikhil Narang, MD Viviana Navas, MD Jenny Thibodeau, MD, MSCS Tariq Ahmad MD MPH
👉 jaccsubmit-heartfailure.org/html/au-contra…

Star studded panel discussing what we need to do to re-invigorate interest in the hf field, who wouldn’t want to work with these legends! HFSA American College of Cardiology Megan Pelter MD Mark Drazner Anu Lala-Trindade Shelley Zieroth Shashank Sinha, MD, MSc, FACC, FAHA BiykemBozkurt Minnow Walsh, MD, MACC Hima Vidula, MD, MS, FACC #ACC2024

Amazing tribute to Dr Valentine Fuster discussing his global impact to cardiovascular medicine by Robert Harrington BiykemBozkurt Kalyanam Shivkumar MD PhD Christopher Kramer MD Dr Roxana Mehran American College of Cardiology Justine Turco

Andrew J Sauer MD Ryan J Tedford MD James Januzzi Jr MD Harriette Van Spall, MD MPH Carlos G Santos-Gallego, MD Jeff Teuteberg Nosheen Reza, MD Jonathan Davis, MD, MPHS Mark Belkin Approximately 6.7 million Americans over 20 years old have HF and the prevalence is expected to ⬆️ 8.5 million by 2030

The lifetime risk of HF increased to 🚨24%🚨
-¼ persons will develop HF in their lifetime

New work in JACC Journals #JACCHF on the treatment effects of ICDs for patients with chronic HFrEF—baseline frailty status significantly modifies risk of all-cause mortality in this large cohort from SCD-HeFT Matt Segar Neil Keshvani ambarish

📎 tinyurl.com/57z4fhfy

Benefits of rapid initiation of quadruple GDMT new diagnosed HFrEF

12 month mortality rates

Quad GDMT vs no GDMT
ARR 24.8%, NNT=4

Quad GDMT vs ACEI/ARB+BB
ARR 10.4%, NNT=10

sciencedirect.com/science/articl…

Join us on Wednesday, March 27th, at noon in Room N315 to welcome our #JTWillersonCVSeminarSeries guest speaker, Dr. Stavros George Drakos.

#cardiovascularresearch #CardioTwitter The Texas Heart Institute From the Labs at Baylor College of Medicine BCM Cardiology

🚨New in JACC Journals w #ACC24

🇺🇸 analysis of newly diagnosed #HFrEF

>4 in 5 pts eligible for quad GDMT

Yet, <1 in 6 prescribed it.

Potentially completely generic triple GDMT (RASi + BB + MRA)??.....only ~4 in 10 eligible pts even prescribed this.

jacc.org/doi/10.1016/j.…

Meet the incredible IC Family of VA Houston! 🎉 Huge shoutout to Ali Denktas (my amazing mentor), Jing Liu, MD & Syed Zaid, MD 🌟

Had a challenging case: 82-year-old male, last vessel with +++ Ca (needed Rota-Shock), LVEF 10-15%, significant PAD.

Of course, the IC fellow was off

This is an incredible resource! kudos to HFSA and BiykemBozkurt and Journal of Cardiac Failure

📣 #JACCHF Call for Papers: #HeartFailure and Management of #Obesity

The journal is inviting submissions for a special themed issue on strategies for the management of obesity and HF. Learn more & submit here: bit.ly/2LUSmcg

BiykemBozkurt Anju Bhardwaj MD FACC Eiran Gorodeski, MD, MPH

Incoming #JACC Editor-in-Chief Dr. Harlan Krumholz has announced the members of his new Editorial Board, each of whom will be responsible for helping to position the journal as the leading beacon for advancing global CV health, effective July 1.

Learn more: bit.ly/3xh2Tpi

'Together, we will transform how a leading medical journal can improve patient outcomes and population health.' #JACC JACC Journals

'These editors will foster a collaborative spirit among the editorial team, authors, reviewers, and JACC staff. Embodying our intent to become an author-centric platform, the editors will engage with authors with the utmost respect, fairness, and kindness”